OBJECTIVE: HIV-infected patients in Africa are vulnerable to severe recurrent infection with Streptococcus pneumoniae, but no effective preventive strategy has been developed. We set out to determine which factors influence in-hospital mortality and long-term survival of Malawians with invasive pneumococcal disease. DESIGN, SETTING AND PATIENTS: Acute clinical features, inpatient mortality and long-term survival were described among consecutively admitted hospital patients with S. pneumoniae in the blood or cerebrospinal fluid. Factors associated with inpatient mortality were determined, and patients surviving to discharge were followed to determine their long-term outcome. RESULTS: A total of 217 patients with pneumococcal disease were stu...
BACKGROUND: HIV infection is a major risk factor for pneumococcal disease in industrialised countrie...
Objective: Adults living with HIV (ALWHIV) on antiretroviral therapy (ART) are at high risk of pne...
AbstractObjective: To determine the differences between human immunodeficiency virus (HIV)-infected ...
OBJECTIVE: HIV-infected patients in Africa are vulnerable to severe recurrent infection with Strepto...
HIV-associated pneumocystis pneumonia (PCP) is increasingly recognized as an important cause of seve...
Objective: HIV-infected adults have high rates of pneumococcal carriage and invasive disease. We inv...
Rationale: In the context of rapid antiretroviral therapy (ART) rollout and an increasing burden o...
BACKGROUND: Pneumocystis jirovecii pneumonia (PCP) remains the leading cause of opportunistic infect...
BACKGROUND: The impact of HIV infection on the evolution of acute community-acquired pneumonia (CAP)...
Objectives: The high seroprevalence of HIV in Malawi might be expected to alter the pattern of patho...
Highly active antiretroviral treatment (HAART) programs have been associated with declines in the bu...
BACKGROUND: Despite a decline in incidence of Pneumocystis jirovecii pneumonia (PCP), severe PCP con...
Highly active antiretroviral treatment (HAART) programs have been associated with declines in the bu...
BackgroundAlthough causing substantial morbidity, the burden of pneumococcal disease among older chi...
RATIONALE In the context of rapid antiretroviral therapy (ART) rollout and an increasing burden of ...
BACKGROUND: HIV infection is a major risk factor for pneumococcal disease in industrialised countrie...
Objective: Adults living with HIV (ALWHIV) on antiretroviral therapy (ART) are at high risk of pne...
AbstractObjective: To determine the differences between human immunodeficiency virus (HIV)-infected ...
OBJECTIVE: HIV-infected patients in Africa are vulnerable to severe recurrent infection with Strepto...
HIV-associated pneumocystis pneumonia (PCP) is increasingly recognized as an important cause of seve...
Objective: HIV-infected adults have high rates of pneumococcal carriage and invasive disease. We inv...
Rationale: In the context of rapid antiretroviral therapy (ART) rollout and an increasing burden o...
BACKGROUND: Pneumocystis jirovecii pneumonia (PCP) remains the leading cause of opportunistic infect...
BACKGROUND: The impact of HIV infection on the evolution of acute community-acquired pneumonia (CAP)...
Objectives: The high seroprevalence of HIV in Malawi might be expected to alter the pattern of patho...
Highly active antiretroviral treatment (HAART) programs have been associated with declines in the bu...
BACKGROUND: Despite a decline in incidence of Pneumocystis jirovecii pneumonia (PCP), severe PCP con...
Highly active antiretroviral treatment (HAART) programs have been associated with declines in the bu...
BackgroundAlthough causing substantial morbidity, the burden of pneumococcal disease among older chi...
RATIONALE In the context of rapid antiretroviral therapy (ART) rollout and an increasing burden of ...
BACKGROUND: HIV infection is a major risk factor for pneumococcal disease in industrialised countrie...
Objective: Adults living with HIV (ALWHIV) on antiretroviral therapy (ART) are at high risk of pne...
AbstractObjective: To determine the differences between human immunodeficiency virus (HIV)-infected ...